Page 8 - Bivalent News Today

Jerusalem, April 14: US pharma giant Pfizers new bivalent mRNA-based Covid booster vaccine has shown to be highly effective in reducing hospitalisation and deaths, particularly in vulnerable patients aged 65 years and above, according to a study published in The Lancet Infectious Diseases.

The updated COVID-19 vaccine booster shots provide virtually no protection against infection and quickly waning shielding against hospitalization, ...

The full story of the trial that had it all.

Last week, the World Health Organisation (WHO) updated its Covid-19 vaccination recommendations, saying healthy children and adolescents may not necessarily need a vaccine, while the elderly and at-risk groups should receive an additional booster dose six to 12 months after their last dose.The

The CDC and the FDA have yet to make a recommendation for another bivalent booster dose, but experts are already recommending it for high-risk groups.

The new bivalent booster is available from April 1. Jamie Morton answers five questions.

The U.S. has yet to decide if there’s a need for another round of bivalent boosters.

Pfizer's COVID-19 vaccine must be administered at least 2 months after the primary vaccination series.

The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.

NEW YORK CITY (dpa-AFX) - The U.S. Food and Drug Administration has authorized bivalent Pfizer-BioNTech covid-19 vaccine as booster dose for certain children 6 months through 4 years of age.In